MCAM and myeloid sarcoma: We and others have previously shown that MCAM expression improves adherence of T-cells in an in vitro model of the BBB (41) and penetration of the blood cerebrospinal fluid barrier (BCSFB) in vitro and in vivo (23, 31) and further, that MCAM expressing T-cells reside to active lesion sites in MS patients (41).